Differential CFSE kinetics pertains to the CD11b+ population. CFSE kinetics were performed on sheep infected with wild-type BLV (no. 2091 [▪], 3002 [▬], 4270 [⧫], 4535 [▴], and 4536 [•] solid lines) or with an attenuated G4 mutant (1071 [▬], 1077 [□], 4537 [⧫], and 4538 [+] dashed lines). Uninfected control animals (dotted lines) were 2147 (□), 3004 (×), 4164 (⋄), 4533 (▵), and 4534 (○). After intravenous CFSE injection in nonsplenectomized (A and B) and splenectomized (C and D) sheep, PBMCs were collected at three selected days and labeled with IgM and CD11b antibodies. Labeled cells were then analyzed by flow cytometry on the basis of 50,000 events. The percentages of cells labeled with CFSE within the B+ CD11b− (panels A and C) and B+ CD11b+ (panels B and D) subpopulations are indicated. Thick arrows label day 27, when the percentages of CFSE-positive B cells of nonsplenectomized BLV-infected sheep reach levels of <5%. Data from unsplenectomized sheep were previously published in reference 10 and are replotted in this work.